Yasugi T - Search Results

1

Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.

Imura M, Yamashita S, Cai LY, Furuta J, Wakabayashi M, Yasugi T, Ushijima T. Imura M, et al. Among authors: yasugi t. Cancer Lett. 2006 Sep 28;241(2):213-20. doi: 10.1016/j.canlet.2005.10.010. Epub 2005 Nov 21. Cancer Lett. 2006. PMID: 16303245

2

Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.

Takada T, Yagi Y, Maekita T, Imura M, Nakagawa S, Tsao SW, Miyamoto K, Yoshino O, Yasugi T, Taketani Y, Ushijima T. Takada T, et al. Among authors: yasugi t. Cancer Sci. 2004 Sep;95(9):741-4. doi: 10.1111/j.1349-7006.2004.tb03255.x. Cancer Sci. 2004. PMID: 15471560 Free PMC article.

3

Silencing of the UCHL1 gene in human colorectal and ovarian cancers.

Okochi-Takada E, Nakazawa K, Wakabayashi M, Mori A, Ichimura S, Yasugi T, Ushijima T. Okochi-Takada E, et al. Among authors: yasugi t. Int J Cancer. 2006 Sep 15;119(6):1338-44. doi: 10.1002/ijc.22025. Int J Cancer. 2006. PMID: 16642472

4

Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers.

Cai LY, Abe M, Izumi S, Imura M, Yasugi T, Ushijima T. Cai LY, et al. Among authors: yasugi t. Life Sci. 2007 Mar 27;80(16):1458-65. doi: 10.1016/j.lfs.2007.01.015. Epub 2007 Jan 20. Life Sci. 2007. PMID: 17303177

5

DNA methylation marker to estimate ovarian cancer cell fraction.

Ebata T, Yamashita S, Takeshima H, Yoshida H, Kawata Y, Kino N, Yasugi T, Terao Y, Yonemori K, Kato T, Ushijima T. Ebata T, et al. Among authors: yasugi t. Med Oncol. 2022 Feb 23;39(5):78. doi: 10.1007/s12032-022-01679-y. Med Oncol. 2022. PMID: 35195779

6

Does aberrant DNA methylation occur in human uterine leiomyomas? An attempt of genome-wide screening by MS-RDA.

Cai LY, Izumi S, Abe M, Imura M, Yasugi T, Wakazono K, Ohnuki Y, Kondo A, Ushijima T. Cai LY, et al. Among authors: yasugi t. Tokai J Exp Clin Med. 2011 Sep 20;36(3):84-90. Tokai J Exp Clin Med. 2011. PMID: 21932190 Free article.

7

DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer.

Ebata T, Yamashita S, Takeshima H, Yoshida H, Kawata Y, Kino N, Yasugi T, Terao Y, Yonemori K, Kato T, Ushijima T. Ebata T, et al. Among authors: yasugi t. Gynecol Oncol. 2022 Dec;167(3):513-518. doi: 10.1016/j.ygyno.2022.10.008. Epub 2022 Oct 15. Gynecol Oncol. 2022. PMID: 36253303

8

Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix.

Minaguchi T, Yoshikawa H, Nakagawa S, Yasugi T, Yano T, Iwase H, Mizutani K, Shiromizu K, Ohmi K, Watanabe Y, Noda K, Nishiu M, Nakamura Y, Taketani Y. Minaguchi T, et al. Among authors: yasugi t. Cancer Lett. 2004 Jul 8;210(1):57-62. doi: 10.1016/j.canlet.2004.03.017. Cancer Lett. 2004. PMID: 15172121

9

Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas.

Matsumoto K, Yoshikawa H, Yasugi T, Onda T, Nakagawa S, Yamada M, Kawana K, Minaguchi T, Oda K, Hasumi Y, Taketani Y. Matsumoto K, et al. Among authors: yasugi t. Cancer Lett. 2002 Jun 6;180(1):83-9. doi: 10.1016/s0304-3835(01)00803-5. Cancer Lett. 2002. PMID: 11911974

10

Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population.

Matsumoto K, Yoshikawa H, Nakagawa S, Tang X, Yasugi T, Kawana K, Sekiya S, Hirai Y, Kukimoto I, Kanda T, Taketani Y. Matsumoto K, et al. Among authors: yasugi t. Cancer Lett. 2000 Aug 11;156(2):159-65. doi: 10.1016/s0304-3835(00)00457-2. Cancer Lett. 2000. PMID: 10880765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters